Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer

被引:0
|
作者
Lu, Shan [1 ]
Oleksowicz, Leslie [1 ]
Liu, Yin [1 ]
Bracken, R. Bruce [1 ]
Gaitonde, Krishnanath [1 ]
Burke, Barbara [1 ]
Succop, Paul [1 ]
Levin, Linda [1 ]
Dong, Zhongyun [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
关键词
D O I
10.1158/1538-7445.AM2012-3631
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3631
引用
收藏
页数:1
相关论文
共 39 条
  • [1] Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer
    Oleksowicz, Leslie
    Liu, Yin
    Bracken, R. Bruce
    Gaitonde, Krishnanath
    Burke, Barbara
    Succop, Paul
    Levin, Linda
    Dong, Zhongyun
    Lu, Shan
    [J]. PROSTATE, 2012, 72 (10): : 1140 - 1149
  • [2] Secretory phospholipase A2-IIa, a potential biomarker for prostate cancer, is regulated by the HER/HER2-elicited pathway
    Oleksowicz, Leslie
    Liu, Yin
    Bracken, R. Bruce
    Gaitonde, Krishnanath
    Burke, Barbara
    Succop, Paul
    Levin, Linda
    Dong, Zhongyun
    Lu, Shan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S53 - S53
  • [3] Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
    Dong, Zhongyun
    Meller, Jaroslaw
    Succop, Paul
    Wang, Jiang
    Wikenheiser-Brokamp, Kathryn
    Starnes, Sandra
    Lu, Shan
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 978 - 984
  • [4] Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
    Elena Kupert
    Marshall Anderson
    Yin Liu
    Paul Succop
    Linda Levin
    Jiang Wang
    Kathryn Wikenheiser-brokamp
    Pingping Chen
    Susan M Pinney
    Trudy Macdonald
    Zhongyun Dong
    Sandra Starnes
    Shan Lu
    [J]. BMC Cancer, 11
  • [5] Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
    Kupert, Elena
    Anderson, Marshall
    Liu, Yin
    Succop, Paul
    Levin, Linda
    Wang, Jiang
    Wikenheiser-brokamp, Kathryn
    Chen, Pingping
    Pinney, Susan M.
    Macdonald, Trudy
    Dong, Zhongyun
    Starnes, Sandra
    Lu, Shan
    [J]. BMC CANCER, 2011, 11
  • [6] Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells
    Lu, Shan
    Dong, Zhongyun
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (06) : 2113 - 2122
  • [7] Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
    Dong, Zhongyun
    Liu, Yin
    Scott, Kieran F.
    Levin, Linda
    Gaitonde, Krishnanath
    Bracken, R. Bruce
    Burke, Barbara
    Zhai, Qihui Jim
    Wang, Jiang
    Oleksowicz, Leslie
    Lu, Shan
    [J]. CARCINOGENESIS, 2010, 31 (11) : 1948 - 1955
  • [8] The EGFR/HER2-elicited multiple pathways in development, progression, and theragnosis of prostate cancer
    Dong, Zhongyun
    Liu, Yin
    Mo, Jun Qin
    Boivin, Gregory
    Levin, Linda
    Oleksowicz, Leslie
    Lu, Shan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S59 - S59
  • [9] Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer
    Dong, Zhongyun
    Liu, Yin
    Levin, Linda
    Oleksowicz, Leslie
    Wang, Jiang
    Lu, Shan
    [J]. ONCOLOGY REPORTS, 2011, 25 (06) : 1511 - 1516
  • [10] HER2 as a potential therapeutic target on quiescent prostate cancer cells
    Yumoto, Kenji
    Rashid, Jibraan
    Ibrahim, Kristina G.
    Zielske, Steven P.
    Wang, Yu
    Omi, Maiko
    Decker, Ann M.
    Jung, Younghun
    Sun, Dan
    Remmer, Henriette A.
    Mishina, Yuji
    Buttitta, Laura A.
    Taichman, Russell S.
    Cackowski, Frank C.
    [J]. TRANSLATIONAL ONCOLOGY, 2023, 31